En Es
Categories

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological functions. The company also provides sequencing and array-based solutions for genetic analysis, as well as genotyping, NIPT and whole-genome sequencing services for government laboratories, hospitals, an ...
Products Summary
Close

About Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological functions. The company also provides sequencing and array-based solutions for genetic analysis, as well as genotyping, NIPT and whole-genome sequencing services for government laboratories, hospitals, and reference laboratories, among others.
FaceBook Twitter Google+ Linked in
NGS Test

NGS Test

Model: MiSeqDx Cystic Fibrosis 139-Variant Assay
Request Information

Description:

The MiSeqDx Cystic Fibrosis 139-Variant Assay is an FDA-cleared in vitro diagnostic (IVD) next-generation sequencing test designed to detect 139 CFTR variants. It provides a fully integrated molecular CF testing solution on the MiSeqDx instrument and includes all index primers and reagents needed for library preparation, sample multiplexing, and sequencing in a single kit.


Send A Message To This Supplier

* Required Information
* Email
To
Illumina (NGS Test)
* Message

Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions